ArticleAnnals of medicine and surgery (2012)2025

Linvoseltamab in multiple myeloma: a BCMA × CD3 bispecific antibody for relapsed and refractory disease.

Ghaniya Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.